AlphaCrest Capital Management’s Silicon Laboratories SLAB Stock Holding History

AlphaCrest Capital Management’s Portfolio SLAB Stock Details SLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,747	Closed	-$339K	–	966
2022 Q3	$339K	Sell	2,747 -1,936	-41%	-$259K	0.02%	1113
2022 Q2	$657K	Buy	4,683 +1,372	+41%	+$192K	0.03%	858
2022 Q1	$497K	Sell	3,311 -5,671	-63%	-$906K	0.03%	896
2021 Q4	$1.85M	Buy	+8,982	New	+$1.65M	0.07%	470
2021 Q2	–	Sell	-4,395	Closed	-$620K	–	1336
2021 Q1	$620K	Buy	4,395 +1,630	+59%	+$234K	0.03%	703
2020 Q4	$352K	Sell	2,765 -999	-27%	-$113K	0.03%	842
2020 Q3	$368K	Buy	3,764 +1,254	+50%	+$126K	0.04%	761
2020 Q2	$252K	Buy	+2,510	New	+$235K	0.04%	719
2020 Q1	–	Sell	-4,520	Closed	-$524K	–	1257
2019 Q4	$524K	Buy	4,520 +2,014	+80%	+$221K	0.04%	760
2019 Q3	$279K	Buy	+2,506	New	+$271K	0.02%	1114
2019 Q1	–	Sell	-4,200	Closed	-$331K	–	948
2018 Q4	$331K	Buy	+4,200	New	+$349K	0.1%	408

Other funds holding SLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

PFO

Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AlphaCrest Capital Management's SLAB Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Silicon Laboratories (SLAB) in Q4 2022, closing a stake of 2,747 shares — an estimated $339K sold.

AlphaCrest Capital Management first reported a position in SLAB in Q4 2018 and held it in 11 quarters. The position peaked at $1.85M in Q4 2021. 310 funds tracked by Wall St. Rank hold SLAB as of Q4 2022.

AlphaCrest Capital Management reported no remaining Silicon Laboratories position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 2,747 Silicon Laboratories shares in Q4 2022, an estimated $339K.
AlphaCrest Capital Management first reported a position in Silicon Laboratories in Q4 2018 and held it in 11 quarters.
AlphaCrest Capital Management's Silicon Laboratories position peaked at $1.85M in Q4 2021.
310 funds tracked by Wall St. Rank held Silicon Laboratories as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.